Ingrid Teige Selected Research

Ingrid Teige Research Topics

10	Neoplasms (Cancer) 11/2022 - 04/2013
6	Inflammation (Inflammations) 01/2010 - 05/2003
3	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2010 - 08/2008
2	Multiple Myeloma 06/2015 - 04/2013
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 11/2022
1	Vaccinia 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Melanoma (Melanoma, Malignant) 01/2018
1	Smoldering Multiple Myeloma 01/2017
1	Disease Progression 06/2015
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 05/2010
1	Hyperplasia 08/2008
1	Rheumatoid Arthritis 12/2005
1	Experimental Arthritis 12/2005
1	Synovitis 03/2005
1	Eosinophilia 03/2005

5	AntibodiesIBA 01/2021 - 04/2015
4	CytokinesIBA 01/2010 - 05/2003
2	AntigensIBA 01/2022 - 11/2018
2	EpitopesIBA 12/2020 - 04/2013
2	IgG Receptors (Fc gamma RI)IBA 01/2019 - 01/2018
2	Monoclonal AntibodiesIBA 01/2017 - 06/2015
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2017 - 04/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2009 - 08/2008
2	Keratin-14 (Keratin 14)IBA 06/2009 - 08/2008
1	Rituximab (Mabthera)FDA Link 11/2022
1	venetoclaxIBA 11/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2022
1	Immunoglobulin G (IgG)IBA 11/2018
1	Member 9 Tumor Necrosis Factor Receptor SuperfamilyIBA 11/2018
1	tremelimumabIBA 01/2018
1	IpilimumabIBA 01/2018
1	Cell Surface ReceptorsIBA 04/2013
1	AutoantigensIBA 05/2010
1	Myelin Basic ProteinIBA 05/2010
1	IntegrinsIBA 01/2010
1	Interleukin-6 (Interleukin 6)IBA 08/2008
1	Interleukin-22 (IL-22)IBA 08/2008
1	Interleukin-17 (Interleukin 17)IBA 08/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2008
1	Interleukin-1beta (Interleukin 1 beta)IBA 08/2008
1	Interleukin-12 (IL 12)IBA 08/2008
1	Interferon-betaIBA 12/2005
1	CPG-oligonucleotideIBA 03/2005
1	Immunoglobulin E (IgE)IBA 03/2005

7	Therapeutics 11/2022 - 03/2005
2	Immunotherapy 11/2022 - 01/2019